<DOC>
	<DOCNO>NCT02136004</DOCNO>
	<brief_summary>The objective trial demonstrate safety effectiveness Rex Medical Closer Vascular Sealing System seal femoral arterial access site .</brief_summary>
	<brief_title>The Closer Trial : A Safety Efficacy Study Rex Medical Vascular Sealing System</brief_title>
	<detailed_description>The objective trial demonstrate safety effectiveness Rex Medical Closer Vascular Sealing System ( VSS ) seal femoral arterial access site provide reduced time hemostasis ( TTH ) compare performance goal completion diagnostic interventional procedure perform 5 , 6 7 Fr procedural sheath . This study consider success ( statistical perspective ) meet Closer VSS superiority goal primary effectiveness analysis Closer VSS performance goal primary safety analysis .</detailed_description>
	<criteria>PreOp 1 Acceptable candidate elective , nonemergent diagnostic interventional endovascular procedure via common femoral artery use 5 , 6 , 7 Fr introducer sheath . PreOperative 1 . Significant bleeding diatheses coagulopathy 2 . Planned endovascular surgical procedure within next 30 day 3 . Planned ipsilateral femoral arteriotomy within next 90 day 4 . Arteriotomy ipsilateral groin within past 30 day residual hematoma , significant bruising vascular complication 5 . Previous vessel closure device use ipsilateral groin within past 90 day 6 . Previous vascular surgery repair vicinity target access site 7 . Severe peripheral vascular disease ipsilateral limb require surgical endovascular treatment within pervious 30 day next 30 day 8 . Existing nerve damage ipsilateral limb 9 . Extreme morbid obesity ( BMI &gt; 4 kg/m2 ) Intraoperative 10 . Use procedural sheath &lt; 5 Fr &gt; 7 Fr 11 . Difficult insertion procedural sheath needle stick problem onset procedure 12 . Placement ipsilateral venous sheath procedure 13 . Procedural sheath placement either superficial femoral artery profunda femoris artery , placement distal bifurcation superficial femoral artery profunda femoris artery 14 . In subject receive unfractionated heparin , ACT &gt; 350 second , &gt; 250 second presence GP IIb/IIIa inhibitor 15 . Procedures exist medical condition may extend index hospitalization beyond 24 hour postprocedure 16 . Systemic hypertension ( SBP &gt; 180 mmHg ) hypotension ( SBP &lt; 90 mmHg ) prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>arteriotomy</keyword>
	<keyword>vessel closure</keyword>
	<keyword>femoral access site</keyword>
</DOC>